NeuroPace IncNPCEEarnings & Financial Report
Nasdaq · Health Care · Surgical & Medical Instruments & Apparatus
NeuroPace Inc is a medical technology company focused on developing and commercializing innovative implantable neurostimulation systems to treat neurological disorders, primarily drug-resistant epilepsy. Its core RNS System delivers personalized responsive stimulation to reduce seizure frequency, serving patients across North America and select global markets via partnerships with healthcare providers.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| OrbiMed Advisors LLC | 11.70% | 3.4M | ▼ -3.50pp | 2024-11-14 |
| NOS. OF ABOVE PERSONS | 2.00% | 582.2K | ▼ -17.00pp | 2024-11-14 |
| FMR LLC | 1.78% | 468.1K | — | 2024-02-09 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-03-20 | LACOB JOSEPH | Director | Grant | 865 | $13.00 | $11.2K |
| 2026-03-20 | Uri Geiger | Director | Grant | 913 | $13.00 | $11.9K |
| 2026-03-20 | Rakhi Kumar | Director | Grant | 1.2K | $13.00 | $15.0K |
| 2026-03-20 | Fischer Frank M | Director | Grant | 1.8K | $13.00 | $23.7K |
1–4 of 4